Benjamin Eldridge
Ben Eldridge co-founded Nutcracker Therapeutics, Inc. and serves as its Chief Technology Officer. As Nutcracker’s systems architect, Ben leads the development of a device-based platform for large scale synthesis of nucleic acids.
Contact
- Email: ***.********@nutcrackerx.com
Companies
Company
Roles
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. is a mRNA manufacturing device founded in 2017 by Igor Khandros.
CTO